VJOncology has assembled a group of leading genitourinary cancer experts to examine and discuss the latest developments in bladder cancer presented at the European Society for Medical Oncology (ESMO) 2021 Annual Meeting.

Listen to this insightful roundtable discussion featuring Laurence Albiges, Gustave Roussy Institute, Villejuif, France, and Enrique Grande, MD Anderson Cancer Center Madrid, Madrid, Spain, to hear about ground-breaking erdafitinib data from NORSE in metastatic or locally advanced urothelial carcinoma, as well as VESPER in muscle-invasive bladder cancer (MIBC). They additionally examine innovative data on pembrolizumab in combination with anti- Ephrin-B2 sEphB4-HSA in advanced urothelial carcinoma.